LifeScience Vaccines
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval in Australia --...
November 01, 2021 | News
Why is the WHO delaying an EUL status to Covaxin?
The World Health Organisation usually takes around 6 to 9 weeks to analyse the data submitted by a vaccine manufacturer and then takes a call on whether to...
October 30, 2021 | Opinion | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."
Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity
Hanmi Science doesn't just want the world to know they are committed to vaccine equity, they want to prove it. Mr. Lim, CEO of Hanmi Science, echoes the co...
October 29, 2021 | News
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom
All modules required for regulatory review, including CMC data, are now complete Submission based on Phase 3 data from ~45K patients demonstrating high ...
October 28, 2021 | News
Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines
The announcement by WHO, comes after the approval from WHO Ethics Review Committee and relevant regulatory authorities and ethics committees of&n...
October 27, 2021 | News
Korean Ginseng Research Institute Announces potential COVID-19 Vaccine Adjuvant Effect of Red Ginseng
The results of the study summarized this time showed that red ginseng increased the effectiveness of the vaccine, so that when red ginseng was taken togeth...
October 22, 2021 | News
Elixirgen Therapeutics Announces Licensing Agreement for Its Novel COVID-19 Vaccine
it has entered into an exclusive licensing agreement with a global pharmaceutical company (currently undisclosed) for the rights to commercialize its self-...
October 11, 2021 | News
Novavax and Serum Announce Submission to WHO for EU Listing of Novavax
Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, w...
September 24, 2021 | News
DHL delivers 1 billion COVID-19 vaccine doses
• 1 billion vaccine doses shipped to more than 160 countries in the fight against COVID-19 since December 2020• Smooth management and execution o...
September 17, 2021 | News
Everest Medicines to Advance mRNA Vaccines in Emerging Markets in Asia
Providence grants Everest license to develop and market potentially "Best-In-Class" mRNA COVID-19vaccine for select Asia territories Provid...
September 15, 2021 | News
Clover Biopharmaceuticals to Produce COVID-19 Vaccine
Clover Biopharmaceuticals, Ltd. (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, toda...
September 14, 2021 | News
J & J Ebola Vaccine booster shots showed strong immune responses
Data show the vaccine regimen induced neutralizing antibody responses in nearly all participating adults and children 21 days after the second dose Adults...
September 14, 2021 | News
GeneQuantum ,BrighGene to develop antibody immune agonist conjugates
GQ1007 is a new type of antibody-drug conjugate. It is an antibody conjugated to a potent immune agonist. In recent years, immunotherapeutic antibody drugs...
September 07, 2021 | News
Moderna Announces Submission of Data to European Medicines Agency for its COVID-19 Vaccine Booster
-Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has submitted for a conditional ...
September 06, 2021 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
